 Supernus Pharmaceuticals, Inc. NASDAQ:SUPN Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Peter Vozzo - ICR Westwicke, Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Amsellem - Piper Sandler Jack Padovano - Stifel Operator Good afternoon and welcome to Supernus Pharmaceuticals Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. 